IL2 and neoplasm: The efficacy of Lm-LLO-CD105A was associated with increased infiltration of polyfunctional (i.e, IFN-γ, TNF-α, and IL-2 producing) CD8+ and CD4+ T cells and reduction in immunosuppression within the TME, and reduced tumor vascularization.